CD28 and cancer: In the future, perhaps it may be possible to use the AI algorithms to construct virtual models for predicting CAR-T functional effects due to mutated CD28 signaling sites, accelerating the understanding of CD28 signaling mechanisms, based on which, combined with existing databases, may be able to provide personalized CD28-based CAR optimization solutions for cancer patients.